Dianthus Therapeutics (DNTH) Misses Q3 EPS by 74c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q3 EPS of ($0.74). Revenue for the quarter came in at $2.17 million.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nutrien warns shareholders about below-market mini-tender offer
• Venu Holding enters $250 million at-the-market stock offering agreement